Literature DB >> 9445183

Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.

S Senba1, F Konishi, T Okamoto, H Kashiwagi, K Kanazawa, M Miyaki, M Konishi, T Tsukamoto.   

Abstract

BACKGROUND: DNA replication errors (RERs) are closely associated with hereditary nonpolyposis colorectal carcinoma (HNPCC). Recently, alterations in DNA mismatch repair genes, including hMSH2, hMLH1, and hPMS2, have been implicated in the pathogenesis of HNPCC: Several studies have demonstrated RER in 13-17% of nonfamilial colorectal carcinomas. It is unclear, however, as to whether or not these RER positive nonfamilial colorectal carcinomas are incomplete forms of HNPCC or are caused by incidental alterations of DNA mismatch repair genes. Consequently, the authors studied the characteristics of RER positive nonfamilial colorectal carcinomas, placing particular emphasis on hMSH2 and hMLH1 gene mutations.
METHODS: Fresh or frozen samples of 103 nonfamilial colorectal carcinomas were examined for RERs using the polymerase chain reaction (PCR) and specific microsatellite primers. The authors also identified mutations of the hMSH2 and hMLH1 genes in RER positive samples by a PCR single strand conformational polymorphism analysis followed by direct nucleotide sequencing.
RESULTS: The incidence of RER was 15.7% (17/103) in nonfamilial colorectal carcinomas, and only 1 case, which was found in the ascending colon, showed a somatic mutation at exon 12 in the hMSH2 gene. Neither germline nor somatic mutations of the hMSH2 or hMLH1 genes could be found in any of the remaining RER positive tumors. RER positive nonfamilial carcinomas tended to be located more frequently in the right colon. There was no increased prevalence in young patients, and the clinicopathologic characteristics of HNPCC were absent in the patients with RER positive nonfamilial colorectal carcinoma.
CONCLUSIONS: Based on these findings, the carcinogenesis of RER positive nonfamilial colorectal carcinoma is considered different from that of HNPCC:

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445183

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Colorectal cancer "methylator phenotype": fact or artifact?

Authors:  Charles Anacleto; Andréia M Leopoldino; Benedito Rossi; Fernando A Soares; Ademar Lopes; José Cláudio C Rocha; Otávia Caballero; Anamaria A Camargo; Andrew J G Simpson; Sérgio D J Pena
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 2.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

3.  Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis?

Authors:  Martin Kruschewski; Aurelia Noske; Jörg Haier; Norbert Runkel; Yanis Anagnostopoulos; Heinz Johannes Buhr
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

4.  DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?

Authors:  H Iino; J R Jass; L A Simms; J Young; B Leggett; Y Ajioka; H Watanabe
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

5.  Pathogenesis of non-familial colorectal carcinomas with high microsatellite instability.

Authors:  K Shitoh; F Konishi; M Miyaki; T Iijima; T Furukawa; T Tsukamoto; H Nagai
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

6.  Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences.

Authors:  T Fujiwara; J M Stolker; T Watanabe; A Rashid; P Longo; J R Eshleman; S Booker; H T Lynch; J R Jass; J S Green; H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

7.  Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer.

Authors:  Sibel Erdamar; Esra Ucaryilmaz; Gokhan Demir; Tayfun Karahasanoglu; Gulen Dogusoy; Ahmet Dirican; Suha Goksel
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

8.  Colonic Paneth cell metaplasia is pre-neoplastic condition of colonic cancer or not?

Authors:  Ryo Wada; Toshikazu Yamaguchi; Kenichi Tadokoro
Journal:  J Carcinog       Date:  2005-02-12

9.  Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.

Authors:  Fulan Hu; Dandan Li; Yibaina Wang; Xiaoping Yao; Wencui Zhang; Jing Liang; Chunqing Lin; Jiaojiao Ren; Lin Zhu; Zhiwei Wu; Shuying Li; Ye Li; Xiaojuan Zhao; Binbin Cui; Xinshu Dong; Suli Tian; Yashuang Zhao
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis.

Authors:  T Løvig; S N Andersen; L Thorstensen; C B Diep; G I Meling; R A Lothe; T O Rognum
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.